Monitor for patient enrollment updates in the OcuRing-K Phase 2 trial before year-end and any strategic partnership announcements for GridFeed. The next material catalyst is likely the initiation of the Phase 2 trial or a GridFeed commercial deal.
Price Chart
Executive Summary
PRF Technologies issued a shareholder letter providing preliminary, unaudited financial highlights for the nine months ended September 30, 2026, including an $11.0 million cash position, $2.5 million in total liabilities, and a $3.7 million operating loss. The company also outlined plans to begin enrolling patients in a Phase 2 trial of OcuRing-K before year-end and to establish GridFeed as a standalone subsidiary targeting AI data center power optimization. The filing is a routine business update with no material financial data or definitive catalysts.
Key Facts
- Preliminary consolidated cash including short-term deposits of approximately $11.0 million as of September 30, 2026.
- Total consolidated liabilities of approximately $2.5 million as of September 30, 2026.
- Consolidated operating loss of approximately $3.7 million for the nine months ended September 30, 2026.
- Raised approximately $10.5 million in gross proceeds through equity line facility during the nine months ended September 30, 2026.
- LayerBio expects to begin enrolling patients in U.S. multi-center Phase 2 trial of OcuRing-K before year-end 2026.
- Plans to establish GridFeed as a standalone wholly owned subsidiary and evaluate AI data center power optimization market.
- PRF-110 demonstrated sustained 72-hour analgesic activity in a head-to-head preclinical study.
- GridFeed engine validated using real-world European utility-scale data; limited initial revenue recognized from first commercial engagements.
Financial Impact
Preliminary cash of $11.0M provides approximately 2-3 quarters of runway at current $3.7M/9-month operating loss run rate (~$1.23M/quarter). No revenue or EPS figures reported.
Risk Factors
- Preliminary and unaudited financials may materially differ from final audited results.
- Phase 2 trial enrollment may be delayed or fail to meet endpoints.
- GridFeed's pivot to data center power optimization is exploratory with no revenue commitments.
- Company has history of significant losses and may require additional capital beyond current cash position.
- Equity line facility usage has been dilutive to existing shareholders.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-004826 |
| Document: zk2636257.htm | 0001178913-26-004826 |
| Document: 0001178913-26-004826-index-headers.html | 0001178913-26-004826 |
| Document: 0001178913-26-004826-index.html | 0001178913-26-004826 |
| Document: 0001178913-26-004826.txt | 0001178913-26-004826 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $0.7400 | awaiting T+60 | — | $0.7393 (−0.09%) |
Oct 23, 2026 3d ago | Press Release | $0.7400 | awaiting T+60 | — | $0.7393 (−0.09%) |
Sep 28, 2026 28d ago | 6-K | $0.9720 | awaiting T+60 | — | $0.7393 (−23.94%) |
Sep 24, 2026 4w ago | SC 13D | $0.9767 | awaiting T+60 | — | $0.7393 (−24.31%) |
Sep 16, 2026 5w ago | 6-K | $1.01 | awaiting T+60 | — | $0.7393 (−26.80%) |
Sep 4, 2026 7w ago | EFFECT | $0.9680 | awaiting T+60 | — | $0.7393 (+23.63%) |
Sep 3, 2026 7w ago | 6-K | $0.9792 | awaiting T+60 | — | $0.7393 (−24.50%) |
Sep 3, 2026 7w ago | Press Release | $0.9792 | awaiting T+60 | — | $0.7393 (−24.50%) |
Jul 27, 2026 13w ago | 6-K | $1.09 $0.7120 | ▼ −34.68% | ▼ −38.38% | $0.7393 (−32.17%) |
Jul 21, 2026 13w ago | 6-K | $1.20 $0.8180 | ▼ −31.83% | ▼ −35.81% | $0.7393 (−38.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers